Brief: Caplin Point Laboratories Unit Receives Final USFDA Approval For ANDA Potassium Phosphates Injection
13/03/2026 06:23
March 13 (Reuters) - Caplin Point Laboratories Ltd CAPL.NS: UNIT RECEIVES FINAL USFDA APPROVAL FOR ANDA POTASSIUM PHOSPHATES INJECTION Source text: ID:nBSEb7BLpZ Further company coverage: CAPL.NS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Caplin Point Laboratories
See all newsBrief: Caplin Point Laboratories Says US FDA Completes Unannounced Inspection Of Caplin Steriles Gummidipoondi Facility
Brief: Caplin Point Laboratories March-Quarter Consol Net Profit 1.7 Bln Rupees
Brief: Caplin Point Laboratories Unit Receives Final USFDA Approval For ANDA Potassium Phosphates Injection
Brief: Caplin Point Laboratories Says Unit Receives USFDA Approval For Sodium Phosphates Injection
Brief: Caplin Point Laboratories Dec-Quarter Consol Net Profit 1.64 Billion Rupees